Clarus Lifesciences I, L.p. - Net Worth and Insider Trading
Clarus Lifesciences I, L.p. Net Worth
The estimated net worth of Clarus Lifesciences I, L.p. is at least $581 Million dollars as of 2024-09-21. Clarus Lifesciences I, L.p. is the 10% Owner of Globus Medical Inc and owns about 7,244,201 shares of Globus Medical Inc (GMED) stock worth over $512 Million. Clarus Lifesciences I, L.p. is the 10% Owner of Oxford Immunotec Global PLC and owns about 2,237,377 shares of Oxford Immunotec Global PLC (OXFD) stock worth over $49 Million. Clarus Lifesciences I, L.p. is also the 10% Owner of Zogenix Inc and owns about 747,805 shares of Zogenix Inc (ZGNX) stock worth over $20 Million. Details can be seen in Clarus Lifesciences I, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Clarus Lifesciences I, L.p. has not made any transactions after 2015-06-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Clarus Lifesciences I, L.p.
Clarus Lifesciences I, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Clarus Lifesciences I, L.p. owns 4 companies in total, including Oxford Immunotec Global PLC (OXFD) , Sientra Inc (SIENQ) , and Globus Medical Inc (GMED) among others .
Click here to see the complete history of Clarus Lifesciences I, L.p.’s form 4 insider trades.
Insider Ownership Summary of Clarus Lifesciences I, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OXFD | Oxford Immunotec Global PLC | 2015-06-16 | 10 percent owner |
| SIENQ | Sientra Inc | 2014-10-28 | 10 percent owner |
| GMED | Globus Medical Inc | 2012-08-08 | 10 percent owner |
 | | 2011-09-16 | 10 percent owner |
Clarus Lifesciences I, L.p. Latest Holdings Summary
Clarus Lifesciences I, L.p. currently owns a total of 3 stocks. Among these stocks, Clarus Lifesciences I, L.p. owns 7,244,201 shares of Globus Medical Inc (GMED) as of August 8, 2012, with a value of $512 Million and a weighting of 88.1%. Clarus Lifesciences I, L.p. owns 2,237,377 shares of Oxford Immunotec Global PLC (OXFD) as of June 16, 2015, with a value of $49 Million and a weighting of 8.47%. Clarus Lifesciences I, L.p. also owns 747,805 shares of Zogenix Inc (ZGNX) as of November 29, 2010, with a value of $20 Million and a weighting of 3.43%.
Latest Holdings of Clarus Lifesciences I, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GMED | Globus Medical Inc | 2012-08-08 | 7,244,201 | 70.64 | 511,730,359 |
| OXFD | Oxford Immunotec Global PLC | 2015-06-16 | 2,237,377 | 21.99 | 49,199,920 |
| ZGNX | Zogenix Inc | 2010-11-29 | 747,805 | 26.68 | 19,951,437 |
Holding Weightings of Clarus Lifesciences I, L.p.
Clarus Lifesciences I, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Clarus Lifesciences I, L.p. has made a total of 0 transactions in Globus Medical Inc (GMED) over the past 5 years. The most-recent trade in Globus Medical Inc is the sale of 804,232 shares on August 8, 2012, which brought Clarus Lifesciences I, L.p. around $9 Million.
According to the SEC Form 4 filings, Clarus Lifesciences I, L.p. has made a total of 0 transactions in Oxford Immunotec Global PLC (OXFD) over the past 5 years. The most-recent trade in Oxford Immunotec Global PLC is the sale of 41,230 shares on June 16, 2015, which brought Clarus Lifesciences I, L.p. around $589,589.
According to the SEC Form 4 filings, Clarus Lifesciences I, L.p. has made a total of 0 transactions in Zogenix Inc (ZGNX) over the past 5 years. The most-recent trade in Zogenix Inc is the acquisition of 218,750 shares on November 29, 2010, which cost Clarus Lifesciences I, L.p. around $7 Million.
Insider Trading History of Clarus Lifesciences I, L.p.
- 1
Clarus Lifesciences I, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Clarus Lifesciences I, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Clarus Lifesciences I, L.p. is 8.72%. GuruFocus also compares Clarus Lifesciences I, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Clarus Lifesciences I, L.p. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Clarus Lifesciences I, L.p.'s insider trading performs compared to the benchmark.
Performance of Clarus Lifesciences I, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 42.56 | | | | | |
| Relative Return to S&P 500(%) | 36.5 | | | | | |
Clarus Lifesciences I, L.p. Ownership Network
Clarus Lifesciences I, L.p. Owned Company Details
What does Oxford Immunotec Global PLC do?
Who are the key executives at Oxford Immunotec Global PLC?
Clarus Lifesciences I, L.p. is the 10 percent owner of Oxford Immunotec Global PLC. Other key executives at Oxford Immunotec Global PLC include director & Chief Executive Officer Peter Wrighton-smith , Chief Financial Officer Mclaughlin Matthew T E , and Chief Operating Officer Stefan C Linn .
Oxford Immunotec Global PLC (OXFD) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Oxford Immunotec Global PLC (OXFD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Oxford Immunotec Global PLC (OXFD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Oxford Immunotec Global PLC (OXFD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Oxford Immunotec Global PLC Insider Transactions
Clarus Lifesciences I, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Clarus Lifesciences I, L.p.. You might contact Clarus Lifesciences I, L.p. via mailing address: 101 Main Street, Suite 1210, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
